Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals
Novartis Pharmaceuticals Corporation today announced the launch of a complimentary dental industry-focused web seminar series entitled �Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals.�
A total of thirty 1-hour web seminars (www.oralhealthwebinar.com) are to be conducted between October and December, and will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.
�Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals� will cover the following topics that every general practice dentist needs to know:
* Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic
bone disease
* Osteonecrosis of the jaw (ONJ) background
* ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
* Review of ONJ studies and management
Please click this link for for more information and complete web seminar schedule.
A total of thirty 1-hour web seminars (www.oralhealthwebinar.com) are to be conducted between October and December, and will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.
�Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals� will cover the following topics that every general practice dentist needs to know:
* Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic
bone disease
* Osteonecrosis of the jaw (ONJ) background
* ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
* Review of ONJ studies and management
Please click this link for for more information and complete web seminar schedule.
Comments